Operating Income (Loss) in USD of BIORA THERAPEUTICS, INC. from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIORA THERAPEUTICS, INC. quarterly/annual Operating Income (Loss) history and change rate from Q1 2019 to Q3 2024.
  • BIORA THERAPEUTICS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2024 was -$16.2M, a 30.4% increase year-over-year.
  • BIORA THERAPEUTICS, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2024 was -$60.9M, a 9.92% increase year-over-year.
  • BIORA THERAPEUTICS, INC. annual Operating Income (Loss) for 2023 was -$67.1M, a 8.68% decline from 2022.
  • BIORA THERAPEUTICS, INC. annual Operating Income (Loss) for 2022 was -$61.8M, a 47.6% increase from 2021.
  • BIORA THERAPEUTICS, INC. annual Operating Income (Loss) for 2021 was -$118M, a 9.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIORA THERAPEUTICS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$60.9M -$16.2M +$7.09M +30.4% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 -$68M -$15.8M -$852K -5.71% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 -$67.1M -$15.5M +$28K +0.18% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$67.1M -$13.3M +$432K +3.14% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024
Q3 2023 -$67.6M -$23.3M -$9.43M -67.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$58.1M -$14.9M -$724K -5.1% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$57.4M -$15.5M +$4.36M +21.9% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$61.8M -$13.8M +$6.38M +31.7% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$68.2M -$13.9M +$16.7M +54.6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$84.8M -$14.2M +$21.4M +60.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$106M -$19.9M +$11.6M +36.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$118M -$20.2M +$31.2M +60.8% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$149M -$30.6M +$105K +0.34% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$149M -$35.7M -$9.17M -34.6% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$140M -$31.5M +$21.1M +40.1% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$161M -$51.4M -$2.4M -4.9% 01 Oct 2020 31 Dec 2020 10-K 18 Mar 2021
Q3 2020 -$159M -$30.7M +$24.2M +44.1% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$183M -$26.5M -$12.2M -85.2% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$171M -$52.5M -$30.5M -139% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$140M -$49M 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 -$54.8M 01 Jul 2019 30 Sep 2019 10-K 18 Mar 2021
Q2 2019 -$14.3M 01 Apr 2019 30 Jun 2019 10-K 18 Mar 2021
Q1 2019 -$22M 01 Jan 2019 31 Mar 2019 10-K 18 Mar 2021

BIORA THERAPEUTICS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$67.1M -$5.36M -8.68% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024
2022 -$61.8M +$56.1M +47.6% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$118M -$10.2M -9.5% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$108M +$32.5M +23.2% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 -$140M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.